Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: The German Stroke Registers Study Group

Stroke

Volumn 34, Issue 5, 2003, Pages 1106-1112

  Heuschmann, Peter U ^a   Berger, Klaus ^a   Misselwitz, Bjoern ^b   Hermanek, Peter ^c   Leffmann, Carsten ^d   Adelmann, Michael ^e   Buecker Nott, Hans Joachim ^f   Rother, Joachim ^g   Neundoerfer, Bernhard ^h   Kolominsky Rabas, Peter L ^h  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Institute of Quality Assurance Hesse   (Germany)

^c Bavarian Perm Working Party Q A   (Germany)

^d Hamburg Hospital Federation   (Germany)

^e Department of Neurology   (Germany)

^f Westphalian Chamber of Physicians ^*  (Germany)

^g UNIVERSITY OF HAMBURG   (Germany)

^h UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Hospital mortality; Stroke; Thrombolytic therapy

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COMMUNITY HOSPITAL; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; GERMANY; HOSPITAL ADMISSION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REGISTER; RISK; SCORING SYSTEM; TREATMENT OUTCOME;

ADULT; AGED; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS; DRUG EVALUATION; FEMALE; FIBRINOLYTIC AGENTS; GERMANY; HOSPITAL DEPARTMENTS; HOSPITAL MORTALITY; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0038304591     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000065198.80347.C5     Document Type: Article

References (27)

1. Wardlaw JM, del Zoppo G, Yamaguchi T. Thrombolysis for acute ischaemic stroke (Cochrane Review). The Cochrane Library. 2001.
2. Tissue plasminogen activator for acute ischemic stroke: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
3. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment With Alteplase to Reverse Stroke (STARS) study. JAMA. 2000;283:1145-1150.
4. Tanne D, Bates VE, Verro P, Kasner SE, Binder JR, Patel SC, Mansbach HH, Daley S, Schultz LR, Karanjia PN, Scott P, Dayno JM, Vereczkey-Porter K, Benesch C, Book D, Coplin WM, Dulli D, Levine SR. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey: the tPA Stroke Survey Group. Neurology. 1999;53:424-427.
5. Grond M, Stenzel C, Schmulling S, Rudolf J, Neveling M, Lechleuthner A, Schneweis S, Heiss WD. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke. 1998;29:1544-1549.
6. Chiu D, Krieger D, Villar-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, Yatsu FM, Grotta JC. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke. 1998;29:18-22.
7. Wang DZ, Rose JA, Honings DS, Garwacki DJ, Milbrandt JC. Treating acute stroke patients with intravenous tPA: the OSF Stroke Network experience. Stroke. 2000;31:77-81.
8. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke. 2001;32:1832-1840.
9. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA. 2000;283:1151-1158.
10. Mohr JP. Thrombolytic therapy for ischemic stroke: from clinical trials to clinical practice. JAMA. 2000;283:1189-1191.
11. Christiansen W, Kunze K, Foerster M. Quality control assessment for stroke management. Cerebrovasc Dis. 1998;8(suppl 4):38. Abstract.
12. Care of stroke patients in the acute phase: initial evaluation of a database for concomitant external quality assurance in Hesse. Arbeitsgruppe Schlaganfall Hessen Akt Neurologie. 1999;26:8-16.
13. Quality Assurance for Accredited Hospitals. Sozialgesetzbuch V. Public Law No. 137. December 17, 1999.
14. Heuschmann PU, Kolominsky-Rabas PL, Kugler C, Leffmann C, Neundorfer B, Haass A, Lowitzsch K, Berger K. Quality assurance in treatment of stroke: basic module of the German Stroke Registry Study Group. Gesundheitswesen. 2000;62:547-552.
15. Kolominsky-Rabas PL, Sarti C, Heuschmann PU, Graf C, Siemonsen S, Neundoerfer B, Katalinic A, Lang E, Gassmann KG, von Stockert TR. A prospective community-based study of stroke in Germany: the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. Stroke. 1998;29:2501-2506.
16. Minister of Health Care (Germany). Dates of the German Health Care System. Schriftenreihe des Bundesministeriums fuer Gesundheit; Bd 91; Baden-Baden: Nomos Verl-Ges; 2001.
17. Kolominsky-Rabas PL, Heuschmann PU, Berger K, Misselwitz B, Haass A, Lowitzsch K, Neundoerfer B, for the German Stroke Registries Study Group. Variations in the acute care of stroke: results from the German Stroke Registries Study Group. Cerebrovasc Dis. 2001;11(suppl 4):90. Abstract.
18. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Org. 1976;54:541-553.
19. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
20. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265-2281.
21. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol. 1999;150:327-333.
22. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33-38.
23. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32:2735-2740.
24. A systems approach to immediate evaluation and management of hyperacute stroke: experience at eight centers and implications for community practice and patient care: the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Stroke. 1997;28:1530-1540.
25. Katzan IL, Sila CA, Furlan AJ. Community use of intravenous tissue plasminogen activator for acute stroke: results of the Brain Matters Stroke Management Survey. Stroke. 2001;32:861-865.
26. Demchuk AM, Tanne D, Hill MD, Kasner SE, Hanson S, Grond M, Levine SR. Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology. 2001;57:474-480.
27. Weir NU, Sandercock PA, Lewis SC, Signorini DF, Warlow CP. Variations between countries in outcome after stroke in the International Stroke Trial (IST). Stroke. 2001;32:1370-1377.